Group III and IV Muscle Afferents: Role on Central Motor Drive and Clinical Implications
Overview
Authors
Affiliations
The present review is focused on neural mechanisms responsible of group III and IV muscle afferent actions on central motor drive during physical exercise in both healthy and pathological populations. It seems that these mechanisms contribute to improve muscle performance by regulating the peripheral fatigue development and by avoiding excessive muscle impairments. Therefore, a great deal of attention is paid to their influences on motor unit activation during fatiguing exercise both in human and animal models. Recent evidence indicated that these afferents from a given active muscle could contribute to regulate the motor activity of the homonymous as well as surrounding skeletal muscles by acting at both spinal and supraspinal levels. In addition, given that the recovery of the sensory feedback plays a key role in the improvement of motor function following numerous neuromuscular traumas, the role of these afferents in preclinical and clinical situations is also explored in animal and human models. It is supposed that studying the motor and autonomic functions of group III and IV afferents might help healthcare professionals in the future to find appropriate treatments and rehabilitation programs.
Kastritseas L, Koutlas A, Kounoupis A, Kritikou S, Papadopoulos S, Smilios I Eur J Appl Physiol. 2024; .
PMID: 39611943 DOI: 10.1007/s00421-024-05670-5.
Zambolin F, Laginestra F, Favaretto T, Giuriato G, Ottaviani M, Schena F Am J Physiol Regul Integr Comp Physiol. 2024; 327(4):R389-R399.
PMID: 39102463 PMC: 11483073. DOI: 10.1152/ajpregu.00069.2024.
The role of clinical neurophysiology in the definition and assessment of fatigue and fatigability.
Tankisi H, Versace V, Kuppuswamy A, Cole J Clin Neurophysiol Pract. 2024; 9:39-50.
PMID: 38274859 PMC: 10808861. DOI: 10.1016/j.cnp.2023.12.004.
Olmos A, Montgomery Jr T, Sears K, Dinyer T, Hammer S, Bergstrom H Eur J Appl Physiol. 2024; 124(6):1807-1820.
PMID: 38236301 DOI: 10.1007/s00421-023-05405-y.
Involvement of the Transient Receptor Channels in Preclinical Models of Musculoskeletal Pain.
Kudsi S, Viero F, Pereira L, Trevisan G Curr Neuropharmacol. 2023; 22(1):72-87.
PMID: 37694792 PMC: 10716882. DOI: 10.2174/1570159X21666230908094159.